ASX:RAP

Email Alerts for:
ASX:RAP

Resources stocks weigh, BNPL stocks catch a bid on tech surge: ASX down 0.2% at noon

06 Jul 2022 - The Australian sharemarket has been choppy this morning in a zig-zag fashion. Information technology shares are leading the gains while resources stocks are lagging, …

ASX stages big rally fueled by RBA-relief, closes 1.4% higher

21 Jun 2022 - Australian shares snapped a 7-day losing streak led by resource and financial stocks amid the US futures pointing to a rise as Wall Street looks to resume trade after…

Stocks of the Hour: ResApp, Radiopharm Theranostics, Reece Pharmaceuticals

21 Jun 2022 - A snapshot of the stocks on the move, featuring ResApp (ASX:RAP), Radiopharm Theranostics (ASX:RAD), and Reece Pharmaceuticals (ASX:RCE).

Relief-rally, sparked by RBA boss says no local recession, Banks jump: ASX up 1.2% at noon

21 Jun 2022 - The ASX is set to snap a 7-day losing streak as investors were relieved that RBA governor Philip Lowe doesn’t see a local recession coming.

Late selloff hit stocks on renewed recession fears, hawkish Fed, Russian oil ban: ASX closes off 1%

31 May 2022 - The Australian sharemarket closed at session lows, snapping its two-day winning streak as concerns mounted on hawkish comments from the Fed and whether the central ba…

Tech blues weigh on miner's rally: ASX retreats 0.3% at noon

31 May 2022 - The Australian sharemarket takes a breather after two days of gains as resources stocks help offset the fall. The improvement in mobility in the world’s second larges…

ResApp Health (ASX:RAP) achieves CE mark for sale of device in Europe

02 Mar 2021 - Digtal health company ResApp Health (ASX:RAP) has achieved CE Mark certification for the company’s wearable device as a Class I medical device accessory.

ResApp Health (ASX:RAP) Presentation, FNN Online Investor Event, December 2020

07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating presents an overview of the company, discussing the addressable market, the benefits of ResA…

ResApp Health (ASX:RAP) - managing respiratory disease and sleep apnoea

07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management o…

ResApp Health (ASX:RAP) signs MoU with RB

18 Jun 2020 - Digital health company, ResApp Health (ASX:RAP) has signed a memorandum of understanding with global health product manufacturer, RB.

A late rally boosts the market, but not enough: ASX closed 0.4% lower

06 May 2020 - The ASX failed to rise into positive territory today closing 0.4% lower. Nearmap (ASX:NEA) shares are on the rise as are Appen (ASX:APX). Shares in National Storage R…

ResApp Health (ASX:RAP) receives final design for devices

06 May 2020 - Digital health company ResApp Health (ASX:RAP) has received a set of final design files, reports and supporting documents for the handheld and wearable devices under …

ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes

15 Nov 2019 - Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasp…

ResApp Health (ASX:RAP) to join Creasphere Digital Health Program

04 Oct 2019 - Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.

NAB shares hit on fresh remediation charges: ASX tracking 1.3% lower at noon

02 Oct 2019 - The ASX opened lower following soft leads from Wall Street and is now tracking 1.3% lower at noon. The markets dropped on poor manufacturing results from the US and w…

Integral Diagnostics (ASX:IDX) appoints Dr Milne: Aus shares close 0.4% lower

30 Sep 2019 - It’s been a bearish afternoon on the Australian share market. The S&P/ASX 200 index closed 0.4% lower. UBS has downgraded Alumina (ASX:AWC) from a neutral to a sell, …

ResApp (ASX:RAP) flags positive results from prospective at-home sleep apnoea study

30 Sep 2019 - ResApp (ASX:RAP) has flagged top-line results from its prospective, blinded at-home obstructive sleep apnoea study.

ResApp Health receives CE Mark approval for Europe

26 Sep 2019 - ResApp Health (ASX:RAP) has received CE Mark approval for ResAppDx-EU version 2, the latest version of the world’s first smartphone-based diagnostic test for respirat…

RBA cut rates to historical low, banks under pressure: Aus shares close 0.1% higher

02 Jul 2019 - Australian share market falls after RBA cut rates as expected to 1%, but the ASX200 claws back into positive territory, rising for the 2nd session. Financials lost ov…

ResApp Health engages UK-based consultant

29 May 2019 - Digital health company ResApp Health (ASX:RAP) has engaged a UK-based medical device consultant to develop customised hardware and wearable devices capable of running…

ResApp share price skyrockets: ASX closes 1 per cent higher

23 Apr 2019 - It has been a positive day of trade for the ASX. After opening in the black the local bourse managed to maintain momentum to gain 1%. Appen (ASX:APX) share price surg…

Study shows ResApp Health algorithms deliver high accuracy

23 Apr 2019 - Digital health smartphone company for respiratory disease, ResApp Health (ASX:RAP) has announced positive top-line results from its Australian Breathe Easy adult clin…

ResApp Health (ASX:RAP) Presentation, FNN Investor Event, November 2018, Sydney

13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…

ResApp Health (ASX:RAP) trials and commercialisation